Integra LifeSciences Reports Quarterly Results
Integra LifeSciences reported results for the quarter ended September 30. The supplied text contains no financial figures.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Maravai LifeSciences Reports Q2 Revenue Growth, Raises EBITDA Guidance
Maravai reported Q2 2026 revenue of $51.4 million, up 9% year over year, and adjusted EBITDA of $8.7 million. It maintained 2026 revenue guidance at $205 million to $215 million and raised adjusted EBITDA guidance to $33 to $35 million.